Clairvoyant (Drug Discovery) Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 12

Employees

  • Latest Deal Type
  • M&A
  • (Cancelled)

  • Investors
  • 7

Clairvoyant (Drug Discovery) General Information

Description

Operator of a biotechnology company intended to offer patients psychedelic therapy to live healthy lives. The company develops psilocybin drug therapy to help patients suffering from substance use disorders and significant mental health conditions, enabling patients to overcome their disorders and significant mental health conditions.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1055 West Georgia Street
  • Suite 2400
  • Vancouver, British Columbia V6E 3P3
  • Canada
+1 (778)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 1055 West Georgia Street
  • Suite 2400
  • Vancouver, British Columbia V6E 3P3
  • Canada
+1 (778)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Clairvoyant (Drug Discovery) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 06-Sep-2024 Cancelled Clinical Trials - Phase 2
3. Early Stage VC (Series A) 03-Apr-2024 Cancelled Clinical Trials - Phase 2
2. Accelerator/Incubator 06-Nov-2023 $2.32M Completed Clinical Trials - Phase 2
1. Seed Round 07-Jul-2022 $2.32M $2.32M Completed Clinical Trials - Phase 2
To view Clairvoyant (Drug Discovery)’s complete valuation and funding history, request access »

Clairvoyant (Drug Discovery) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Clairvoyant (Drug Discovery) Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Empowered Startups Accelerator/Incubator
Ambria Capital Venture Capital Minority
Iter Investments Venture Capital Minority
Kodori Venture Capital Minority
Negev Capital Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Clairvoyant (Drug Discovery) FAQs

  • When was Clairvoyant (Drug Discovery) founded?

    Clairvoyant (Drug Discovery) was founded in 2021.

  • Where is Clairvoyant (Drug Discovery) headquartered?

    Clairvoyant (Drug Discovery) is headquartered in Vancouver, Canada.

  • What is the size of Clairvoyant (Drug Discovery)?

    Clairvoyant (Drug Discovery) has 12 total employees.

  • What industry is Clairvoyant (Drug Discovery) in?

    Clairvoyant (Drug Discovery)’s primary industry is Drug Discovery.

  • Is Clairvoyant (Drug Discovery) a private or public company?

    Clairvoyant (Drug Discovery) is a Private company.

  • What is Clairvoyant (Drug Discovery)’s current revenue?

    The current revenue for Clairvoyant (Drug Discovery) is .

  • How much funding has Clairvoyant (Drug Discovery) raised over time?

    Clairvoyant (Drug Discovery) has raised $2.32M.

  • Who are Clairvoyant (Drug Discovery)’s investors?

    Empowered Startups, Ambria Capital, Iter Investments, Kodori, and Negev Capital are 5 of 7 investors who have invested in Clairvoyant (Drug Discovery).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process